Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances: NEPTUNE Clinical Guidance

Description

There are global concerns about the proliferation and misuse of club drugs and novel psychoactive substances, yet we know little about their harms and research on clinical management and treatment remains limited. This book fills the knowledge gap by providing a detailed overview of the research evidence available to date. The book provides a framework that allows readers to understand this large number of new drugs, using classifications based on primary psychoactive effect. Within this framework, the book provides detailed reviews of the more commonly used drugs. Each chapter explores pharmacology, patterns and mode of use, acute and chronic harms, and clinical interventions supported by research evidence. An invaluable resource for clinical staff, this book will support clinicians working in the emergency department, substance misuse and addiction services, mental health services, primary care, sexual health services and more. It will also be of interest to academics and those developing drug policy. Tackles a global public health issue and clinical challenges of rapidly changing drug patterns and limited knowledge of the harms of new psychoactive substances Provides a detailed summary of the up-to-date research evidence on the main club drugs and novel psychoactive substances Improves clinicians' ability to understand new substances that will emerge Offers authoritative and comprehensive guidance accessible to a wide range of clinicians and other practitioners working within substance misuse/addiction services, emergency departments, primary care, sexual health and mental health services Acknowledgements vi Part I Introduction and Background 1 AnIntroduction to Club Drugs and Novel Psychoactive Substances 1 2 PsychosocialInterventionsfor Club Drugsand Novel Psychoactive Substances 22 Part II Drugs with Primarily Depressant Effects 3 Gamma-Hydroxybutyrate (GHB) and GammaButyrolactone (GBL) 37 4 NewBenzodiazepine Novel Psychoactive Substances 65 5 Synthetic Opioid Novel Psychoactive Substances (Fentanyl and Non-fentanyl) 78 6 Ketamine and Other Novel Psychoactive Substances with Dissociative Effects 101 7 Nitrous Oxide (N2O) 131 Part III Drugs with Primarily Stimulant Effects 8A Introduction to Stimulant Club Drugs and Novel Psychoactive Substances 143 8B Amphetamine-type Stimulants: An Overview 146 9 ‘Ecstasy’: MDMA (3,4-Methylenedioxy-NMethylamphetamine), MDMA Analogues and Drugs with Similar Effects 165 10 Methamphetamine 202 11 Synthetic Cathinones 240 Part IV Drugs with Primarily Hallucinogenic Effects 12 Hallucinogenic Drugs 267 Part V Synthetic Cannabinoid Receptor Agonists 13 Synthetic Cannabinoid Receptor Agonists 299 Part VI Concluding Remarks 14 Conclusion 329 Index 330